Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 7/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28324445 | 1.00 | EPHX1 (0.41) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL22551590 | 0.90 | LMNA (0.37) | LMNABLM | |
| SCHEMBL5844523 | 0.89 | EPHX1 (0.38) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL27857861 | 0.82 | EPHX1 (0.38) | EPHX1TP53DPP4 | |
| SCHEMBL28324333 | 0.80 | EPHX1 (0.43) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL3500350 | 0.80 | EPHX1 (0.43) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL11803465 | 0.78 | EPHX1 (0.42) | EPHX1TP53KDM4EGMNNLMNA | |
| SCHEMBL29074463 | 0.78 | DPP4 (0.39) | DPP4 | |
| SCHEMBL23781756 | 0.78 | S1PR2 (0.35) | — | |
| SCHEMBL28901368 | 0.77 | LMNA (0.31) | LMNABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735620-A1 | METHODS AND FORMULATIONS FOR DENATURING DNA | Illumina, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2025003421-A1 | METHODS AND FORMULATIONS FOR DENATURING DNA | ILLUMINA, INC. (US) | 2025-01-02 | — | — | WO | claimed |
| EP-3280444-B1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB LLC (US) | 2024-05-08 | — | — | EP | claimed |
| EP-4263690-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2023-10-25 | — | — | EP | claimed |
| WO-2022132962-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS GROUP, LLC (US) | 2022-06-23 | — | — | WO | claimed |
| EP-3762339-A1 | METHODS AND COMPOSITIONS TO REDUCE AZOLES AND AOX CORROSION INHIBITORS | BL Technologies, Inc. (US) | 2021-01-13 | — | — | EP | claimed |
| US-20180079797-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB, LLC | 2018-03-22 | — | — | US | claimed |
| EP-3280444-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | Adimab, LLC (US) | 2018-02-14 | — | — | EP | claimed |
| WO-2016196207-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | WATER LENS, LLC. (US) | 2016-12-08 | — | — | WO | claimed |
| WO-2016164708-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB, LLC (US) | 2016-10-13 | — | — | WO | claimed |
| EP-3016965-A1 | ALKALINE ACTIVATION FOR IMMOBILIZATION OF DNA TAGGANTS | Applied DNA Sciences Inc. (US) | 2016-05-11 | — | — | EP | claimed |
| EP-3003385-A1 | ANTIBODY COMPOSITION AND BUFFER SYSTEM THEREFOR | Innova Biosciences Limited (GB) | 2016-04-13 | — | — | EP | claimed |
| WO-2015002677-A1 | ALKALINE ACTIVATION FOR IMMOBILIZATION OF DNA TAGGANTS | APPLIED DNA SCIENCES INC. (US) | 2015-01-08 | — | — | WO | claimed |
| WO-2014191560-A1 | ANTIBODY COMPOSITION AND BUFFER SYSTEM THEREFOR | INNOVA BIOSCIENCES LTD (GB) | 2014-12-04 | — | — | WO | claimed |
| WO-2014143864-A2 | METHODS OF DETECTING INFLUENZA VIRUS | UNIVERSITY OF CINCINNATI (US) | 2014-09-18 | — | — | WO | claimed |
| CN-1753961-B | Cmp composition comprising a sulfonic acid and a method for polishing noble metals | CABOT MICROELECTRONICS CORP | 2010-08-11 | — | — | CN | claimed |
| EP-1740284-A2 | SEPARATIONS PLATFORM BASED UPON ELECTROOSMOSIS-DRIVEN PLANAR CHROMATOGRAPHY | Perkinelmer Las, Inc. (US) | 2007-01-10 | — | — | EP | claimed |
| CN-1753961-A | Cmp composition comprising a sulfonic acid and a method for polishing noble metals | CABOT MICROELECTRONICS CORP (US) | 2006-03-29 | — | — | CN | claimed |
| WO-2005092013-A2 | SEPARATIONS PLATFORM BASED UPON ELECTROOSMOSIS-DRIVEN PLANAR CHROMATOGRAPHY | PERKINELMER LAS, INC. (US) | 2005-10-06 | — | — | WO | claimed |
| JP-62175668-A | — | — | None | — | — | JP | disclosed |
| EP-4735620-A1 | METHODS AND FORMULATIONS FOR DENATURING DNA | Illumina, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12379345-B2 | Method of purity determination by capillary electrophoresis | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4520798-A1 | POLISHING COMPOSITION AND METHOD FOR POLISHING SUBSTRATE USING THE COMPOSITION | Fujimi Incorporated (JP) | 2025-03-12 | — | — | EP | disclosed |
| WO-2025003421-A1 | METHODS AND FORMULATIONS FOR DENATURING DNA | ILLUMINA, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024145200-A1 | CHARGE BALANCED POLYMERS FOR INDUSTRIAL WATER APPLICATIONS | BL TECHNOLOGIES, INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| EP-4367235-A1 | COMPOSITIONS AND METHODS FOR DETECTING GENETIC FEATURES | Singular Genomics Systems, Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| EP-3280444-B1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB LLC (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-4359786-A1 | MASS SPECTROMETRY-COMPATIBLE PH GRADIENT BUFFER SYSTEM | Phenomenex, Inc. (US) | 2024-05-01 | — | — | EP | disclosed |
| WO-2024057324-A1 | PLASMA-ACTIVATED COMPOSITIONS AND METHODS OF USE THEREOF | NOVA PLASMA LTD. (IL) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023240090-A1 | ENHANCING CLUSTERING EFFICIENCY AND KINETICS | ILLUMINA, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230393094-A1 | METHOD OF PURITY DETERMINATION BY CAPILLARY ELECTROPHORESIS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-12-07 | — | — | US | disclosed |
| EP-4271839-A1 | PHASE PROTECTIVE REAGENT FLOW ORDERING | Singular Genomics Systems, Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-4263690-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230265501-A1 | PHASE PROTECTIVE REAGENT FLOW ORDERING | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-08-24 | — | — | US | disclosed |
| EP-4153606-A2 | METHODS OF SEQUENCING COMPLEMENTARY POLYNUCLEOTIDES | Singular Genomics Systems, Inc. (US) | 2023-03-29 | — | — | EP | disclosed |
| EP-4142740-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Synedgen, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-4117682-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2023-01-18 | — | — | EP | disclosed |
| WO-2023283090-A1 | COMPOSITIONS AND METHODS FOR DETECTING GENETIC FEATURES | Singular Genomics Systems, Inc. (US) | 2023-01-12 | — | — | WO | disclosed |
| WO-2022271853-A1 | MASS SPECTROMETRY-COMPATIBLE PH GRADIENT BUFFER SYSTEM | PHENOMENEX, INC. (US) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022272150-A2 | LINKED TRANSCRIPT SEQUENCING | Singular Genomics Systems, Inc. (US) | 2022-12-29 | — | — | WO | disclosed |
| WO-2022197942-A1 | PHASE PROTECTIVE REAGENT FLOW ORDERING | Singular Genomics Systems, Inc. (US) | 2022-09-22 | — | — | WO | disclosed |
| WO-2022132962-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS GROUP, LLC (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2021221656-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | SYNEDGEN, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| WO-2021222727-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | SYNEDGEN, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| EP-3803387-A1 | MITOCHONDRIAL CONDUCTANCE INHIBITORS AND METHODS OF USE THEREOF | The Regents of The University of California (US) | 2021-04-14 | — | — | EP | disclosed |
| US-20210047387-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB LLC (US) | 2021-02-18 | — | — | US | disclosed |
| EP-3762339-A1 | METHODS AND COMPOSITIONS TO REDUCE AZOLES AND AOX CORROSION INHIBITORS | BL Technologies, Inc. (US) | 2021-01-13 | — | — | EP | disclosed |
| EP-3759461-A1 | SAMPLE PREPARATION FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING | Selux Diagnostics, Inc. (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10787500-B2 | Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species | ADIMAB, LLC (US) | 2020-09-29 | — | — | US | disclosed |
| EP-3440223-A1 | PROCESS FOR CELL LYSIS AND NUCLEIC ACID AMPLIFICATION | 3M Innovative Properties Company (US) | 2019-02-13 | — | — | EP | disclosed |
| EP-3430160-A1 | DETECTION OF CELLS IN A LIQUID SAMPLE | Delta Instruments B.V. (NL) | 2019-01-23 | — | — | EP | disclosed |
| WO-2018140590-A1 | SEFT-LABELING MINIPROTEINS AND CONJUGATES COMPRISING THEM | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-08-02 | — | — | WO | disclosed |
| US-20180079797-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB, LLC | 2018-03-22 | — | — | US | disclosed |
| CN-107735069-A | Dental adhesive | 登特斯普伊德特雷有限公司 | 2018-02-23 | — | — | CN | disclosed |
| EP-3280444-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | Adimab, LLC (US) | 2018-02-14 | — | — | EP | disclosed |
| CN-105378466-B | Anion sensors | 株式会社日立高新技术 | 2017-11-24 | — | — | CN | disclosed |
| WO-2017176469-A1 | PROCESS FOR CELL LYSIS AND NUCLEIC ACID AMPLIFICATION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-10-12 | — | — | WO | disclosed |
| WO-2017158431-A1 | DETECTION OF CELLS IN A LIQUID SAMPLE | DELTA INSTRUMENTS B.V. (NL) | 2017-09-21 | — | — | WO | disclosed |
| EP-3212781-A2 | SERINE PROTEASES | Danisco US Inc. (US) | 2017-09-06 | — | — | EP | disclosed |
| EP-3212662-A1 | SERINE PROTEASES | Danisco US Inc. (US) | 2017-09-06 | — | — | EP | disclosed |
| WO-2016196207-A1 | COMPOSITIONS, APPARATUS, AND METHODS FOR DETERMINING HARDNESS OF WATER AND MAGNESIUM ION IN AN ANALYTE COMPOSITION | WATER LENS, LLC. (US) | 2016-12-08 | — | — | WO | disclosed |
| WO-2016164708-A1 | METHODS FOR PURIFYING HETERODIMERIC MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY SPECIES | ADIMAB, LLC (US) | 2016-10-13 | — | — | WO | disclosed |
| EP-1836161-B1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BHI LTD PARTNERSHIP (CA) | 2016-07-20 | — | — | EP | disclosed |
| EP-1836161-B1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BHI LTD PARTNERSHIP (CA) | 2016-07-20 | — | — | EP | disclosed |
| EP-3016965-A1 | ALKALINE ACTIVATION FOR IMMOBILIZATION OF DNA TAGGANTS | Applied DNA Sciences Inc. (US) | 2016-05-11 | — | — | EP | disclosed |
| WO-2016069548-A2 | SERINE PROTEASES | DANISCO US INC. (US) | 2016-05-06 | — | — | WO | disclosed |
| WO-2016069552-A1 | SERINE PROTEASES | DANISCO US INC. (US) | 2016-05-06 | — | — | WO | disclosed |
| WO-2016066885-A1 | A METHOD TO MEASURE PHOSPHONATES | AQSENS OY (FI) | 2016-05-06 | — | — | WO | disclosed |
| EP-3003385-A1 | ANTIBODY COMPOSITION AND BUFFER SYSTEM THEREFOR | Innova Biosciences Limited (GB) | 2016-04-13 | — | — | EP | disclosed |
| US-9195215-B2 | Holographic medium having a protective layer | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-11-24 | — | — | US | disclosed |
| EP-2920586-A1 | IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY | F. Hoffmann-La Roche SA (CH) | 2015-09-23 | — | — | EP | disclosed |
| WO-2015002677-A1 | ALKALINE ACTIVATION FOR IMMOBILIZATION OF DNA TAGGANTS | APPLIED DNA SCIENCES INC. (US) | 2015-01-08 | — | — | WO | disclosed |
| WO-2014191560-A1 | ANTIBODY COMPOSITION AND BUFFER SYSTEM THEREFOR | INNOVA BIOSCIENCES LTD (GB) | 2014-12-04 | — | — | WO | disclosed |
| US-20140329746-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2014-11-06 | — | — | US | disclosed |
| US-20140329746-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2014-11-06 | — | — | US | disclosed |
| US-20140329746-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2014-11-06 | — | — | US | disclosed |
| CN-102574915-B | Antibodies that specifically bind to Abeta oligomers and uses thereof | IMMUNAS PHARMA, INC. (JP) | 2014-10-22 | — | — | CN | disclosed |
| US-20140295329-A1 | HOLOGRAPHIC MEDIUM HAVING A PROTECTIVE LAYER | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-10-02 | — | — | US | disclosed |
| US-8835654-B2 | Method and compositions for treating amyloid-related diseases | BHI LIMITED PARTNERSHIP (CA) | 2014-09-16 | — | — | US | disclosed |
| US-8835654-B2 | Method and compositions for treating amyloid-related diseases | BHI LIMITED PARTNERSHIP (CA) | 2014-09-16 | — | — | US | disclosed |
| US-8835654-B2 | Method and compositions for treating amyloid-related diseases | BHI LIMITED PARTNERSHIP (CA) | 2014-09-16 | — | — | US | disclosed |
| CN-103946325-A | Aqueous coating compositions | CYTEC AUSTRIA GMBH | 2014-07-23 | — | — | CN | disclosed |
| WO-2014078729-A1 | IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY | GENENTECH, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| EP-2721681-A1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | Fluidic, Inc. (US) | 2014-04-23 | — | — | EP | disclosed |
| EP-2683817-A2 | THERMOSTABLE CARBONIC ANHYDRASES AND METHODS OF USE THEREOF | Danisco US Inc. (US) | 2014-01-15 | — | — | EP | disclosed |
| CN-103068881-A | Polylactic acid block copolymer | TORAY INDUSTRIES | 2013-04-24 | — | — | CN | disclosed |
| CN-103068880-A | Method for producing polylactic acid block copolymer | TORAY INDUSTRIES | 2013-04-24 | — | — | CN | disclosed |
| WO-2012154735-A9 | THERMOSTABLE CARBONIC ANHYDRASES AND METHODS OF USE THEREOF | DANISCO US INC. (US) | 2013-04-18 | — | — | WO | disclosed |
| WO-2012174531-A1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | FLUIDIC, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012154735-A2 | THERMOSTABLE CARBONIC ANHYDRASES AND METHODS OF USE THEREOF | DANISCO US INC. (US) | 2012-11-15 | — | — | WO | disclosed |
| CN-102596997-A | Antibodies that specifically bind to A beta oligomers and use thereof | IMMUNAS PHARMA INC | 2012-07-18 | — | — | CN | disclosed |
| CN-102574915-A | Antibodies that specifically bind to Abeta oligomers and uses thereof | IMMUNAS PHARMA INC | 2012-07-11 | — | — | CN | disclosed |
| CN-102459335-A | Antibodies that specifically bind to Abeta oligomers and uses thereof | IMMUNAS PHARMA INC | 2012-05-16 | — | — | CN | disclosed |
| WO-2012037150-A1 | CRYSTAL STRUCTURES OF O-GLCNAC TRANSFERASE AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-03-22 | — | — | WO | disclosed |
| US-20120015911-A1 | METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BELLUS HEALTH INC. (CA) | 2012-01-19 | — | — | US | disclosed |
| US-20120015911-A1 | METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BELLUS HEALTH INC. (CA) | 2012-01-19 | — | — | US | disclosed |
| US-20120015911-A1 | METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BELLUS HEALTH INC. (CA) | 2012-01-19 | — | — | US | disclosed |
| US-20110294911-A1 | POLYURETHANE SURFACTANT STABILIZED POLYURETHANE FOAMS | BAYER MATERIALSCIENCE AG (DE) | 2011-12-01 | — | — | US | disclosed |
| US-20110275728-A1 | DISPERSED TWO-COMPONENT POLYURETHANE FOAMS | BAYER MATERIALSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
| US-8044100-B2 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH INC. (CA) | 2011-10-25 | — | — | US | disclosed |
| US-8044100-B2 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH INC. (CA) | 2011-10-25 | — | — | US | disclosed |
| US-8044100-B2 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH INC. (CA) | 2011-10-25 | — | — | US | disclosed |
| US-20110171277-A1 | WOUND DRESSING HAVING A POLYURETHANE FOAM LAYER AND A COVER LAYER MADE OF THERMOPLASTIC POLYMER | BAYER MATERIALSCIENCE AG (DE) | 2011-07-14 | — | — | US | disclosed |
| CN-102124105-A | Antibody capable of specifically binding to Abeta oligomer and application thereof | IMMUNAS PHARMA INC | 2011-07-13 | — | — | CN | disclosed |
| CN-101080429-B | Water-based coating compositions comprising thiol-functional compounds | AKZO NOBEL COATINGS INT BV | 2010-10-13 | — | — | CN | disclosed |
| CN-101117468-B | Ink-jet ink, method for preparing the ink-jet ink | RICOH KK | 2010-09-22 | — | — | CN | disclosed |
| EP-2222350-A2 | BIOMEDICAL FOAM ARTICLES | Bayer Innovation GmbH (DE) | 2010-09-01 | — | — | EP | disclosed |
| CN-1753961-B | Cmp composition comprising a sulfonic acid and a method for polishing noble metals | CABOT MICROELECTRONICS CORP | 2010-08-11 | — | — | CN | disclosed |
| EP-2197931-A2 | POLYURETHANE FOAMS FOR WOUND MANAGEMENT | Bayer Innovation GmbH (DE) | 2010-06-23 | — | — | EP | disclosed |
| US-20090263431-A1 | POLYURETHANE FOAMS FOR WOUND MANAGEMENT | BAYER INNOVATION GMBH (DE) | 2009-10-22 | — | — | US | disclosed |
| CN-101511897-A | Aqueous compositions of sagging control agents | DU PONT (US) | 2009-08-19 | — | — | CN | disclosed |
| EP-2078041-A2 | FUSION PROTEINS COMPRISING TWO OR MORE IGG BINDING DOMAINS OF STREPTOCOCCAL PROTEIN G. | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2009-07-15 | — | — | EP | disclosed |
| US-20090155779-A1 | APTAMERS THAT BIND TO PRION PROTEIN | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-06-18 | — | — | US | disclosed |
| WO-2009043498-A2 | POLYURETHANE FOAMS FOR WOUND MANAGEMENT | BAYER INNOVATION GMBH (DE) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009043499-A2 | BIOMEDICAL FOAM ARTICLES | BAYER INNOVATION GMBH (DE) | 2009-04-09 | — | — | WO | disclosed |
| US-20090092647-A1 | POLYURETHANE FOAMS FOR WOUND MANAGEMENT | BAYER MATERIALSCIENCE AG (DE) | 2009-04-09 | — | — | US | disclosed |
| CN-100475957-C | Novel gluconate dehydratase | MITSUI CHEMICALS INC (JP) | 2009-04-08 | — | — | CN | disclosed |
| US-20090054542-A1 | EO/PO BLOCK COPOLYMERS USEFUL AS STABILIZERS FOR PUR FOAMS | BAYER MATERIALSCIENCE AG (DE) | 2009-02-26 | — | — | US | disclosed |
| CN-101313042-A | Compositions and methods for chemical mechanical polishing of tantalum | CABOT MICROELECTRONICS CORP (US) | 2008-11-26 | — | — | CN | disclosed |
| EP-1844141-A4 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | FUJIFILM CORP (JP) | 2008-11-05 | — | — | EP | disclosed |
| WO-2008035217-A2 | FUSION PROTEINS COMPRISING TWO OR MORE IGG BINDING DOMAINS OF STREPTOCOCCAL PROTEIN G. | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2008-03-27 | — | — | WO | disclosed |
| EP-1896850-A2 | APTAMERS THAT BIND TO PRION PROTEIN | The Ohio State University Research Foundation (US) | 2008-03-12 | — | — | EP | disclosed |
| CN-101128421-A | Methods and compositions for treating amyloid-related diseases | NEUROCHEM INTERNAT LTD (CH) | 2008-02-20 | — | — | CN | disclosed |
| CN-101117468-A | Ink-jet ink, method for preparing the ink-jet ink | RICOH KK (JP) | 2008-02-06 | — | — | CN | disclosed |
| CN-101080429-A | Water-based coating compositions comprising thiol-functional compounds | AKZO NOBEL COATINGS INT BV (NL) | 2007-11-28 | — | — | CN | disclosed |
| EP-1853705-A1 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | Fujifilm Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
| EP-1853704-A1 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | Fujifilm Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
| EP-1844141-A1 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | FUJIFILM Corporation (JP) | 2007-10-17 | — | — | EP | disclosed |
| EP-1844140-A1 | METHOD FOR PREPARING SAMPLE SOLUTION AND SAMPLE SOLUTION PREPARING APPARATUS | FUJIFILM Corporation (JP) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006138676-A2 | APTAMERS THAT BIND TO PRION PROTEIN | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2006-12-28 | — | — | WO | disclosed |
| US-20060223855-A1 | reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2006-10-05 | — | — | US | disclosed |
| WO-2006093325-A1 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | FUJIFILM CORPORATION (JP) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006093330-A1 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | FUJIFILM CORPORATION (JP) | 2006-09-08 | — | — | WO | disclosed |
| WO-2006083017-A1 | METHOD FOR SEPARATING AND PURIFYING NUCLEIC ACID | FUJIFILM CORPORATION (JP) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006080579-A1 | METHOD FOR PREPARING SAMPLE SOLUTION AND SAMPLE SOLUTION PREPARING APPARATUS | FUJIFILM CORPORATION (JP) | 2006-08-03 | — | — | WO | disclosed |
| US-20060078745-A1 | Formable composite films of plastic and composite elements of plastic coated with soft touch coating, and the production thereof | BAYER MATERIALSCIENCE AG | 2006-04-13 | — | — | US | disclosed |
| CN-1753961-A | Cmp composition comprising a sulfonic acid and a method for polishing noble metals | CABOT MICROELECTRONICS CORP (US) | 2006-03-29 | — | — | CN | disclosed |
| CN-1597942-A | Novel gluconate dehydratase | MITSUI CHEMICALS INC (JP) | 2005-03-23 | — | — | CN | disclosed |
| CN-1134539-C | Thrombopoietin | ��Ĭɭ�����ѧ����˾ | 2004-01-14 | — | — | CN | disclosed |
| US-6638503-B2 | Extraction of actinokinase | MAHARASHTRA ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2003-10-28 | — | — | US | disclosed |
| US-20030170221-A1 | STREPTOMYCES MEGASPORUS SD5, PROCESS FOR THE ISOLATION THEREOF, NOVEL FIBRINOLYTIC ENZYME PREPARED THEREFROM, PROCESS FOR THE PRODUCTION OF SAID ENZYME AND METHOD OF TREATMENT OF THROMBOLYTIC DISORDERS USING SAID ENZYME | MAHARASHTRA ASSOC. FOR THE CULTIVATION OF SCIENCE | 2003-09-11 | — | — | US | disclosed |
| WO-1998001550-A2 | VACCINE AGAINST GASTRO-INTESTINAL NEMATODES | UNIVERSITEIT UTRECHT (NL) | 1998-01-15 | — | — | WO | disclosed |
| CN-1141061-A | Thrombopoietin | GENENTECH INC (US) | 1997-01-22 | — | — | CN | disclosed |
| CN-1114358-A | Isolation, quantitation and purification of insecticidal proteins from endotoxins of bacillus thuringiensis | CA NAT RESEARCH COUNCIL (CA) | 1996-01-03 | — | — | CN | disclosed |
| US-5460948-A | Enzymatically converting salicylate to a catechol, reacting the catechol with 4-aminophenazone to produce a dye; colorimetric, quantiatative analysis | THE PUBLIC HEALTH LABORATORY SERVICE BOARD (GB) | 1995-10-24 | — | — | US | disclosed |
| EP-0396584-B1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES | MICROBIOLOGICAL RES AUTHORITY (GB) | 1995-01-25 | — | — | EP | disclosed |
| EP-0396584-A1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES. | HEALTH LAB SERVICE BOARD (GB) | 1990-11-14 | — | — | EP | disclosed |
| WO-1989005356-A1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES | THE PUBLIC HEALTH LABORATORY SERVICE BOARD (GB) | 1989-06-15 | — | — | WO | disclosed |
| JP-S62175668-A | METHOD OF MEASURING CALCIUM | SHINOTESUTO KENKYUSHO:KK | 1987-08-01 | — | — | JP | disclosed |
| EP-0224162-A2 | Photosensitive polycondensation product containing diazonium groups, their production process and photosensitive registration material containing this polycondensate | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-06-03 | — | — | EP | disclosed |
| EP-0224162-A2 | Photosensitive polycondensation product containing diazonium groups, their production process and photosensitive registration material containing this polycondensate | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223855-A1 | reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity | APP, IAPP, BACE1 | EPHX1 812/4885TP53 1511/4885KDM4E 4831/4885 |
| US-20090263431-A1 | POLYURETHANE FOAMS FOR WOUND MANAGEMENT | FGB, F2, F8 | EPHX1 1950/4885TP53 2598/4885KDM4E 1689/4885 |
| US-20140329746-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | APP, PSEN1, PSEN2 | EPHX1 574/4885TP53 1545/4885KDM4E 4713/4885 |
| US-20110171277-A1 | WOUND DRESSING HAVING A POLYURETHANE FOAM LAYER AND A COVER LAYER MADE OF THERMOPLASTIC POLYMER | PUF60, KRT18, CUTA | EPHX1 780/4885TP53 1814/4885KDM4E 3475/4885 |
| US-20120015911-A1 | METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | APP, PSEN1, PSEN2 | EPHX1 592/4885TP53 2048/4885KDM4E 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.